281 related articles for article (PubMed ID: 6132413)
21. A review of the safety profiles of benzodiazepine hypnotics.
Roth T; Roehrs TA
J Clin Psychiatry; 1991 Sep; 52 Suppl():38-41. PubMed ID: 1680124
[TBL] [Abstract][Full Text] [Related]
22. Rebound insomnia and newer hypnotics.
Lader M
Psychopharmacology (Berl); 1992; 108(3):248-55. PubMed ID: 1523276
[TBL] [Abstract][Full Text] [Related]
23. Rebound insomnia.
Hartse KM; Roth T; Piccione PM; Zorick FJ
Science; 1980 Apr; 208(4442):423-4. PubMed ID: 6102800
[No Abstract] [Full Text] [Related]
24. Benzodiazepine hypnotics: carryover effectiveness, rebound insomnia, and performance effects.
Kales A
NIDA Res Monogr; 1980; (33):61-9. PubMed ID: 6119616
[No Abstract] [Full Text] [Related]
25. [The withdrawal syndrome in benzodiazepine dependence and its management].
Străulea AO; Chiriţă V
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological treatment of insomnia.
Maczaj M
Drugs; 1993 Jan; 45(1):44-55. PubMed ID: 7680984
[TBL] [Abstract][Full Text] [Related]
27. Hypnotic drugs for 1984.
Oswald I
Psychopharmacology Suppl; 1984; 1():84-90. PubMed ID: 6147844
[TBL] [Abstract][Full Text] [Related]
28. The use of short- and long-acting hypnotics in clinical medicine.
Nicholson AN
Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):61S-69S. PubMed ID: 6133538
[TBL] [Abstract][Full Text] [Related]
29. Drug treatment of insomnia: indications and complications.
Syvälahti EK
Ann Clin Res; 1985; 17(5):265-72. PubMed ID: 3909922
[TBL] [Abstract][Full Text] [Related]
30. [Benzodiazepines and sleep].
Ansseau M
Acta Psychiatr Belg; 1985; 85(4):522-32. PubMed ID: 2865871
[TBL] [Abstract][Full Text] [Related]
31. Main neuroendocrine features and therapy in primary sleep troubles.
Amihăesei IC; Mungiu OC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
[TBL] [Abstract][Full Text] [Related]
32. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
Lader MH
Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S399-405. PubMed ID: 10622686
[TBL] [Abstract][Full Text] [Related]
33. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
[TBL] [Abstract][Full Text] [Related]
34. Insomnia and its treatment. When are hypnotics justified?
Malcolm R; Gross JA
Postgrad Med; 1984 Jul; 76(1):83-90. PubMed ID: 6146130
[TBL] [Abstract][Full Text] [Related]
35. Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby JA; Kales JD
Clin Pharmacol Ther; 1986 Mar; 39(3):345-52. PubMed ID: 2868823
[TBL] [Abstract][Full Text] [Related]
36. [Phenazepam: to the question of the efficacy and safety of benzodiazepine derivatives].
Nenasteva AY
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):156-161. PubMed ID: 29376999
[TBL] [Abstract][Full Text] [Related]
37. Situation and problem of administration methods and the intermission of hypnotics.
Uchimura N; Takeuchi N; Kuwahara H; Nose I; Hashizume Y; Shirakawa S; Ohyama T; Maeda H
Psychiatry Clin Neurosci; 2002 Jun; 56(3):295-6. PubMed ID: 12047602
[TBL] [Abstract][Full Text] [Related]
38. Hypnotics: rebound insomnia and residual sequelae.
Nicholson AN
Br J Clin Pharmacol; 1980 Mar; 9(3):223-5. PubMed ID: 7362730
[No Abstract] [Full Text] [Related]
39. Quazepam and flurazepam: long-term use and extended withdrawal.
Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby J; Kales JD
Clin Pharmacol Ther; 1982 Dec; 32(6):781-8. PubMed ID: 7140142
[TBL] [Abstract][Full Text] [Related]
40. Consensus conference. Drugs and insomnia. The use of medications to promote sleep.
JAMA; 1984 May; 251(18):2410-4. PubMed ID: 6142971
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
